معرفی
Joseph Ibrahim is an Alumni Distinguished Professor in the Department of Biostatistics at the Gillings School of Global Public Health, University of North Carolina at Chapel Hill, where he has served since 2002. He currently holds dual leadership roles as Director of Graduate Studies for the Department of Biostatistics and Director of the Biostatistics for Research in Genomics and Training Grant. His methodological innovations in Bayesian survival analysis and missing data methodologies have significantly advanced public health research, particularly in cancer genomics applications.
Professor Ibrahim's research program centers on developing statistical frameworks for complex clinical and genomic data. His seminal contributions include Bayesian cure rate models, prior elicitation techniques, and diagnostic tools for high-dimensional survival analysis. Current work focuses on integrating multi-omics data with longitudinal tumor burden metrics and refining adaptive clinical trial designs for biomarker-driven populations. These methodologies directly address critical challenges in precision oncology and pharmacovigilance, enabling more robust inference from real-world evidence.
His 2025 publications reveal three dominant trends: (1) Advancements in cure rate modeling for joint longitudinal-survival data with change points, (2) Computational innovations for high-dimensional penalized models using autoencoders and R packages like hdbayes, and (3) Methodological refinements for Bayesian trial design incorporating historical controls. These works consistently bridge theoretical statistics with cancer research applications, particularly in tumor phylogeny inference and signal detection for adverse events.
Scientific awards include:
- Samuel S. Wilks Memorial Award (2024) from the American Statistical Association for distinguished contributions to biostatistics
Professor Ibrahim has mentored 48 pre-doctoral students and 8 postdoctoral fellows, with exceptional thesis publication records in top statistical journals. As principal investigator of the T32 Cancer Genomics Training Grant since 2004, he has secured funding for 35 doctoral students. His curriculum leadership includes modernizing eight graduate courses and establishing new data science computing sequences since 2015. Current advising focuses on Bayesian methodology development for cancer genomics applications.
He directs the department's Biostatistics for Research in Genomics initiative and leads the T32 Cancer Genomics Training Grant team, which integrates statistical methodology development with translational cancer research across UNC's Lineberger Comprehensive Cancer Center and clinical partners.
